Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Carotid and renal artery stents are expandable tubes that are implanted in narrowed arteries to increase the flow of blood. GlobalData uses proprietary data and analytics to provide a comprehensive report on the carotid and renal artery stents market in Taiwan. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the carotid and renal artery stents market in Taiwan was Abbott Laboratories followed by Biotronik SE & Co, Boston Scientific, Medtronic and Terumo.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries. Carotid stenosis is further divided into two indications: symptomatic and asymptomatic carotid stenosis. Patients with symptomatic carotid stenosis can present with symptoms such as transient ischemic attacks or temporary vision loss. But in cases of asymptomatic carotid stenosis, there are no such symptoms. Carotid artery stenosis is a major contributor to ischemic stroke. Renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. Renal arteries can become narrowed due to plaque formation in the inner surface of the arteries. A Carotid artery BMS is a metal-mesh tube that is implanted to increase the flow of blood in a narrowed carotid artery. A Renal artery BMS is a metal-mesh tube that is implanted to increase blood flow in a narrowed renal artery. Transcarotid Stent System is a nitinol self- expanding stent that is implanted to form a lattice to cover narrowed carotid artery and to push outward on the luminal surface, helping to maintain the carotid artery.

The carotid and renal artery stents market in Taiwan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size carotid and renal artery stents in Taiwan, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.